The global and southeast Asia protein purification & isolation market has been segmented by product into instruments and consumables. The consumables segment is further divided into kits, reagents, columns, resins and magnetic beads. The kits segment registered the largest market share of 29.27% along with a value of USD 612.70 million in the year 2019 and is anticipated to reach a value of USD 1518.07 million by the end of 2030 by growing at a CAGR of 8.60% during the forecast period. Kit is a tool used for the purification and preparation of proteins from tissues or cells and can isolate protein from large samples of tissue or cultured cells. The kits help to prepare whole lysates and specific cellular fractions which is especially important when performing 2D electrophoresis by reducing the complexity making the analysis much easier. On the other hand, consumables are components which are used along with instruments in protein purification and isolation.
The global and southeast Asia protein purification & isolation market is segmented by regions into North America, Latin America, Europe, Asia Pacific, South East Asia and Middle East and Africa. Among these regions, the market in North America registered the largest market share of 26.14% along with a value of USD 1638.48 million in the year 2019 and is expected to reach a value of USD 4111.92 million by the end of 2030 by growing at a CAGR of 8.72% during the forecast period. The market in the region is thriving on the back of numerous factors, including increasing research in pharmaceutical and biotechnological fields, growing demand for rapid purification kits in rapidly screen test, paradigm shift towards automated instrumentation for protein purification and growth of proteomics market. Additionally, increasing demand for specialized drugs, presence of a large number of market players, developed research and development infrastructure and the increasing technological advancements in the proteomics field are some of the additional factors anticipated to drive the market growth in the region.
The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).CLICK TO DOWNLOAD SAMPLE REPORT
Growing Need for More Accurate and Purification Kit
Purified proteins are required for an array of experimental applications, including structural studies and in vitro biochemical assays. Proteins can be obtained by the overexpression in yeast, bacteria or mammalian cells in culture or from a tissue. Based on differences in their physical properties, protein purification involves isolating proteins from the source. The objective of a protein purification is to retain the largest amount of the functional protein with fewest contaminants. The purification of a protein must be optimized to complete this process in the least number of steps. Moreover, there is also an increase in demand for technologically advanced techniques backed by the growing need for accurate identification of several new protein molecules, coupled with the purification and isolation of functional proteins with minimum contaminants. Rapid purification kits are required to decrease the time taken for purification and isolation with the same efficacy. Affinity tags are extensively used for the isolation and purification of proteins as these facilitate efficient purification in a single step. The rising need to accurately identify new ligands and develop rapid purification kits that can screen, prepare, purify, and concentrate protein samples are anticipated to drive the growth of the global and southeast Asia protein purification & isolation market.
Increasing Research & Developmental Activities
Governing bodies are increasingly investing in R&D and undertaking initiatives that promote the development and growth of pharmaceutical and biotechnology markets. For protein purification and isolation solutions, pharmaceutical is a highly lucrative industry owing to the significant investments for the development of biomarker specific molecules. In the preclinical drug development phase, precise isolation of proteins with a significant amount of purified substrate is a vital component. On the other hand, technological advancements in the protein purification and isolation process, such as the increasing preference for magnetic and protein beads and ligand tagging system over traditional methods, such as agarose beads and other resins, coupled with the rising utilization of automated analysers are anticipated to drive the growth of the global and southeast Asia protein purification & isolation market.
High Cost of Instruments and Tools
The high costs of instruments and tools hampers the adoption rate of the protein purification and isolation solutions dramatically. Additionally, the difficulties observed in maintaining one size that fits all purification kits of sample preparation in laboratory, coupled with the factors such as the high costs and problems with scaling up the purification and isolation processes and the doubts on the efficiency of the solutions are some of the factors anticipated to limit the growth of the global and southeast Asia protein purification & isolation market.
Some of the affluent industry leaders in the global and southeast Asia protein purification & isolation market are Thermo Fisher Scientific Inc., Merck KGaA, Sigma-Aldrich Co., QIAGEN GmbH, Bio-Rad Laboratories, Inc., Agilent Technologies, General Electric Company, Abcam plc and F. Hoffmann-La Roche Ltd.
July 2020: Thermo Fisher Scientific Inc. and First Genetics JCS formed a collaborative partnership focused on commercializing next-generation sequencing (NGS)-based diagnostics in Russia.
July 2020: Merck KGaA plans to build a new USD 19.96 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: Growing need amongst researchers and laboratory analysts to reduce the contamination during the extraction and isolation process of proteins, is one of the major factors that is driving the growth of the market.
Ans: The market is anticipated to attain a CAGR of 8.65% over the forecast period, i.e. 2021-2030.
Ans: The market in Europe is anticipated to display significant business opportunities in the future.
Ans: The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, Sigma-Aldrich Co., QIAGEN GmbH, Bio-Rad Laboratories, Inc., Agilent Technologies, General Electric Company, Abcam plc and F. Hoffmann-La Roche Ltd.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is majorly segmented by product, technology and by region.
Ans: The kits segment, which is a sub-segment of the consumables segment under product segment, held the largest market share of 29.27% in the year 2019 and is anticipated to display significant growth opportunity.
Ans: High costs of instruments and tools that are required for the extraction and isolation processes of proteins is one of the major factors anticipated to act as a barrier towards the growth of the global and southeast Asia protein purification & isolation m